Open Access
Research Article

Table 2

Fourteen differential peaks were detected in sera from newly developed advanced schistosomiasis (NDAS) cases when compared to sera from healthy controls using MALDI-TOF-MS and ClinProTools analysis.

m/z Peak amplitude
p
Control group NDAS group
5905 775.00 ± 425.26 265.1 ± 205.1 0.00317
5943 70.98 ± 44.01 22.14 ± 6.53 0.00317
2953 62.49 ± 31.99 28.06 ± 10.8 0.00317
2082 51.67 ± 37.16 173.00 ± 120.97 0.0054
3884 51.28 ± 29.95 28.85 ± 13.22 0.024
1945 93.94 ± 73.26 205.9 ± 142.84 0.0249
4282 52.79 ± 90.67 235.4 ± 245.63 0.0254
924 98.45 ± 85.43 40.57 ± 17.4 0.0276
5337 116.8 ± 83.75 60.43 ± 46.13 0.0423
3241 108.7 ± 52.58 76.59 ± 27.40 0.0496
9289 165.82 ± 124.86 90.63 ± 63.89 0.0495
7766 297.88 ± 192.94 178.61 ± 121.2 0.0494
2661 119.30 ± 129.47 69.27 ± 37.72 0.0493
2991 76.9 ± 79.66 42.4 ± 55.15 0.0490

Note. Data are expressed as mean ± SD.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.